Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Editorial Commentary on "The role of periodontal microorganisms in the pathogenesis of myocardial infarction. From PCR techniques to microbiome sequencing".

Magan-Fernandez A, Castellino G, Cappello F, Mesa F.

Trends Cardiovasc Med. 2020 Feb 29. pii: S1050-1738(20)30032-3. doi: 10.1016/j.tcm.2020.02.006. [Epub ahead of print] No abstract available.

PMID:
32192823
2.

Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study.

Castellino G, Nikolic D, Magán-Fernández A, Malfa GA, Chianetta R, Patti AM, Amato A, Montalto G, Toth PP, Banach M, Cicero AFG, Rizzo M.

Nutrients. 2019 Oct 25;11(11). pii: E2580. doi: 10.3390/nu11112580.

3.

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers.

Corina A, Abrudan MB, Nikolic D, Cӑtoi AF, Chianetta R, Castellino G, Citarrella R, Stoian AP, Pérez-Martínez P, Rizzo M.

Curr Pharm Des. 2019;25(35):3704-3714. doi: 10.2174/1381612825666191105111232.

PMID:
31692432
4.

Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.

Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M.

Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10.

PMID:
30759365
5.

Periodontitis and mechanisms of cardiometabolic risk: Novel insights and future perspectives.

Mesa F, Magan-Fernandez A, Castellino G, Chianetta R, Nibali L, Rizzo M.

Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):476-484. doi: 10.1016/j.bbadis.2018.12.001. Epub 2018 Dec 5. Review.

6.

Natural approaches in metabolic syndrome management.

Patti AM, Al-Rasadi K, Giglio RV, Nikolic D, Mannina C, Castellino G, Chianetta R, Banach M, Cicero AFG, Lippi G, Montalto G, Rizzo M, Toth PP.

Arch Med Sci. 2018 Mar;14(2):422-441. doi: 10.5114/aoms.2017.68717. Epub 2017 Jul 19.

7.

Management of Statin Intolerance in 2018: Still More Questions Than Answers.

Toth PP, Patti AM, Giglio RV, Nikolic D, Castellino G, Rizzo M, Banach M.

Am J Cardiovasc Drugs. 2018 Jun;18(3):157-173. doi: 10.1007/s40256-017-0259-7. Review.

8.

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.

Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A.

Cardiovasc Diabetol. 2016 Dec 3;15(1):162.

9.

PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.

Nikolic D, Castellino G, Banach M, Toth PP, Ivanova E, Orekhov AN, Montalto G, Rizzo M.

Curr Pharm Des. 2017 Mar 26;23(6):894-902. doi: 10.2174/1381612822666161006151134. Review.

PMID:
27719644
10.

[The extra-glycemic effects of liraglutide: focus on cardiometabolic markers].

Giglio RV, Patti AM, Nikolic D, Castellino G, Noto M, Parrino A, Montalto G, Rizzo M.

G Ital Cardiol (Rome). 2016 Apr;17(4):253-8. doi: 10.1714/2214.23896. Review. Italian.

PMID:
27093208
11.

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

Toth PP, Patti AM, Nikolic D, Giglio RV, Castellino G, Biancucci T, Geraci F, David S, Montalto G, Rizvi A, Rizzo M.

Front Pharmacol. 2016 Jan 6;6:299. doi: 10.3389/fphar.2015.00299. eCollection 2015.

Supplemental Content

Loading ...
Support Center